Zou X, Fang S, Yuan G, Shen G
Department of Neurology, First Affiliated Hospital, Chengdu.
Hua Xi Yi Ke Da Xue Xue Bao. 1997 Sep;28(3):304-6.
For further understanding the changes in immune function of the patients with hemorrhagic stroke, we investigated the activity of interleukin-2 (IL-2) in the peripheral blood T lymphocytes from 32 patients. The results showed that the levels of IL-2 in the patients were lower than those of the healthy controls, but no significant difference was observed between the cerebral hemorrhage group and subarachnoid hemorrhage group. It suggests the cellular immune function of patients at the acute period is low. We consider that IL-2 might be of use as a kind of therapeutic measure to modulate patients' immune function and treat the diseases.
为进一步了解出血性中风患者免疫功能的变化，我们检测了32例患者外周血T淋巴细胞中白细胞介素-2（IL-2）的活性。结果显示，患者IL-2水平低于健康对照组，但脑出血组与蛛网膜下腔出血组之间无显著差异。这表明急性期患者的细胞免疫功能低下。我们认为IL-2可能作为一种调节患者免疫功能和治疗疾病的治疗措施。
